ID   A0A0D0M4G2_9FLAO        Unreviewed;       864 AA.
AC   A0A0D0M4G2;
DT   29-APR-2015, integrated into UniProtKB/TrEMBL.
DT   29-APR-2015, sequence version 1.
DT   27-MAR-2024, entry version 29.
DE   SubName: Full=Glycosyl hydrolase family 3 {ECO:0000313|EMBL:KIQ25514.1};
GN   ORFNames=RT99_00965 {ECO:0000313|EMBL:KIQ25514.1};
OS   Flavobacterium sp. MEB061.
OC   Bacteria; Bacteroidota; Flavobacteriia; Flavobacteriales;
OC   Flavobacteriaceae; Flavobacterium.
OX   NCBI_TaxID=1587524 {ECO:0000313|EMBL:KIQ25514.1, ECO:0000313|Proteomes:UP000032091};
RN   [1] {ECO:0000313|EMBL:KIQ25514.1, ECO:0000313|Proteomes:UP000032091}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MEB061 {ECO:0000313|EMBL:KIQ25514.1,
RC   ECO:0000313|Proteomes:UP000032091};
RA   Perisin M.A., Vetter M., Gilbert J.A., Bergelson J.;
RT   "16Stimator: statistical estimation of ribosomal gene copy numbers from
RT   draft genome assemblies.";
RL   Submitted (DEC-2014) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: The sequence shown here is derived from an EMBL/GenBank/DDBJ
CC       whole genome shotgun (WGS) entry which is preliminary data.
CC       {ECO:0000313|EMBL:KIQ25514.1}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JXQR01000002; KIQ25514.1; -; Genomic_DNA.
DR   RefSeq; WP_042562829.1; NZ_JXQR01000002.1.
DR   AlphaFoldDB; A0A0D0M4G2; -.
DR   OrthoDB; 9805821at2; -.
DR   Proteomes; UP000032091; Unassembled WGS sequence.
DR   GO; GO:0009044; F:xylan 1,4-beta-xylosidase activity; IEA:InterPro.
DR   GO; GO:0045493; P:xylan catabolic process; IEA:InterPro.
DR   Gene3D; 3.40.50.1700; Glycoside hydrolase family 3 C-terminal domain; 2.
DR   Gene3D; 3.20.20.300; Glycoside hydrolase, family 3, N-terminal domain; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR044993; BXL.
DR   InterPro; IPR026891; Fn3-like.
DR   InterPro; IPR002772; Glyco_hydro_3_C.
DR   InterPro; IPR036881; Glyco_hydro_3_C_sf.
DR   InterPro; IPR001764; Glyco_hydro_3_N.
DR   InterPro; IPR036962; Glyco_hydro_3_N_sf.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR037524; PA14/GLEYA.
DR   InterPro; IPR011658; PA14_dom.
DR   NCBIfam; NF041776; xylosidase_Xyl3A; 1.
DR   PANTHER; PTHR42721:SF3; BETA-D-XYLOSIDASE 5-RELATED; 1.
DR   PANTHER; PTHR42721; SUGAR HYDROLASE-RELATED; 1.
DR   Pfam; PF14310; Fn3-like; 1.
DR   Pfam; PF00933; Glyco_hydro_3; 1.
DR   Pfam; PF01915; Glyco_hydro_3_C; 1.
DR   Pfam; PF07691; PA14; 1.
DR   PRINTS; PR00133; GLHYDRLASE3.
DR   SMART; SM01217; Fn3_like; 1.
DR   SMART; SM00758; PA14; 1.
DR   SUPFAM; SSF51445; (Trans)glycosidases; 1.
DR   SUPFAM; SSF56988; Anthrax protective antigen; 1.
DR   SUPFAM; SSF52279; Beta-D-glucan exohydrolase, C-terminal domain; 1.
DR   PROSITE; PS51820; PA14; 1.
PE   4: Predicted;
KW   Hydrolase {ECO:0000256|ARBA:ARBA00022801, ECO:0000313|EMBL:KIQ25514.1};
KW   Signal {ECO:0000256|ARBA:ARBA00022729, ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           20..864
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002227707"
FT   DOMAIN          458..600
FT                   /note="PA14"
FT                   /evidence="ECO:0000259|PROSITE:PS51820"
SQ   SEQUENCE   864 AA;  96526 MW;  43B99803F5DB5A48 CRC64;
     MKISYLFIIS LVSIFSANAQ QYRFKDASLS STERAKDLIS RLTLEEKAAL MCDQSDPIPR
     LGIKKFNWWS EALHGYANND NVTVFPEPIG MAASFDDQLV YNVFNAVSDE ARAKYNQWIQ
     GGNENKRFLS LSVWTPNVNI FRDPRWGRGQ ETYGEDPYLT SRMGISVVKG LQGPADAKYR
     KLLACAKHFA VHSGPEWSRH ELNLNNIDPR ELYETYLPAF KALVQDADVR QVMCAYQRLD
     DEPCCSNTRL LQRILRDEWG FKYLVVSDCG AVTDFYTTHK VSSDATHAAS KAVLAGTDVE
     CVWQKYPFKN LPEAVEKDLI KEADIDKSLL RVLTGRFDLG EMDDDAIVPW AQIPASVLNS
     KEHQQLALEM AQKSMTLLQN KNNILPLNKT INKVAVIGPN ADNEPMLWGN YNGTPVKTIT
     IKSGIQSKIA ENKMVYDKAC DLVEDKVNQS YFDQLSFEGK KGMKATYWNN PNREGNSVIA
     QQIVNPIKMT TAGQHEFASG VKLEGFSAKY ETEFTAKEND SLVFKTGATG AFELLVNDKS
     LAKYTNWRTL PGKIKFAVEA GKKYKIEILY AQSNNWQANL EFDFGKEHDI NFAALIQKLK
     GIDTVIFVGG LSTLLEGEEM PVSYPGFKGG DRTNIELPAV QRKCLQELKA AGKKVVFVNC
     SGSAIALTPE TASCDAILQA WYPGESGGQA VADVLFGDYN PAGKLPVSFY KNSEILGDFE
     DYSMKGRTYR YTTDVLFPFG FGLSYSKFQI GKANLSKTNI KPTENTQLNF SIKNTSKREG
     TEIVQVYVRK VNDTDGPLKT LKAFKRITLK AGESQNATID LPASSFEFYD AKSIGMKVTA
     GEYEVFYGTS SDAKDLKMNK VSIQ
//